Shechter M - Search Results

1

Impact of acute caffeine ingestion on endothelial function in subjects with and without coronary artery disease.

Shechter M, Shalmon G, Scheinowitz M, Koren-Morag N, Feinberg MS, Harats D, Sela BA, Sharabi Y, Chouraqui P. Shechter M, et al. Am J Cardiol. 2011 May 1;107(9):1255-61. doi: 10.1016/j.amjcard.2010.12.035. Epub 2011 Feb 23. Am J Cardiol. 2011. PMID: 21349479 Clinical Trial.

2

Additional ST segment elevation during the first hour of thrombolytic therapy: an electrocardiographic sign predicting a favorable clinical outcome.

Shechter M, Rabinowitz B, Beker B, Motro M, Barbash G, Kaplinsky E, Hod H. Shechter M, et al. J Am Coll Cardiol. 1992 Dec;20(7):1460-4. doi: 10.1016/0735-1097(92)90437-r. J Am Coll Cardiol. 1992. PMID: 1452918 Free article.

3

Beneficial effect of magnesium sulfate in acute myocardial infarction.

Shechter M, Hod H, Marks N, Behar S, Kaplinsky E, Rabinowitz B. Shechter M, et al. Am J Cardiol. 1990 Aug 1;66(3):271-4. doi: 10.1016/0002-9149(90)90834-n. Am J Cardiol. 1990. PMID: 2195862 Clinical Trial.

4

Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy.

Shechter M, Hod H, Chouraqui P, Kaplinsky E, Rabinowitz B. Shechter M, et al. Am J Cardiol. 1995 Feb 15;75(5):321-3. doi: 10.1016/s0002-9149(99)80546-3. Am J Cardiol. 1995. PMID: 7856520 Clinical Trial.

5

Frequency and prognostic significance of secondary ventricular fibrillation complicating acute myocardial infarction. SPRINT Study Group.

Behar S, Reicher-Reiss H, Shechter M, Rabinowitz B, Kaplinsky E, Abinader E, Agmon J, Friedman Y, Barzilai J, Kauli N, et al. Behar S, et al. Among authors: shechter m. Am J Cardiol. 1993 Jan 15;71(2):152-6. doi: 10.1016/0002-9149(93)90730-z. Am J Cardiol. 1993. PMID: 8421975

6

Acute myocardial infarction without thrombolytic therapy: beneficial effects of magnesium sulfate.

Shechter M, Hod H, Chouraqui P, Kaplinsky E, Rabinowitz B. Shechter M, et al. Herz. 1997 Jun;22 Suppl 1:73-6. doi: 10.1007/BF03042658. Herz. 1997. PMID: 9259191 Clinical Trial.

7

Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease.

Shechter M, Merz CN, Paul-Labrador M, Meisel SR, Rude RK, Molloy MD, Dwyer JH, Shah PK, Kaul S. Shechter M, et al. Am J Cardiol. 1999 Jul 15;84(2):152-6. doi: 10.1016/s0002-9149(99)00225-8. Am J Cardiol. 1999. PMID: 10426331 Clinical Trial.

8

Oral magnesium therapy improves endothelial function in patients with coronary artery disease.

Shechter M, Sharir M, Labrador MJ, Forrester J, Silver B, Bairey Merz CN. Shechter M, et al. Circulation. 2000 Nov 7;102(19):2353-8. doi: 10.1161/01.cir.102.19.2353. Circulation. 2000. PMID: 11067788 Clinical Trial.

9

Improvement in endothelium-dependent brachial artery flow-mediated vasodilation with low-density lipoprotein cholesterol levels <100 mg/dl.

Shechter M, Sharir M, Labrador MJ, Forrester J, Merz CN. Shechter M, et al. Am J Cardiol. 2000 Dec 1;86(11):1256-9, A6. doi: 10.1016/s0002-9149(00)01214-5. Am J Cardiol. 2000. PMID: 11090803

10

Effects of oral magnesium therapy on exercise tolerance, exercise-induced chest pain, and quality of life in patients with coronary artery disease.

Shechter M, Bairey Merz CN, Stuehlinger HG, Slany J, Pachinger O, Rabinowitz B. Shechter M, et al. Am J Cardiol. 2003 Mar 1;91(5):517-21. doi: 10.1016/s0002-9149(02)03297-6. Am J Cardiol. 2003. PMID: 12615252 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

151 results

Search Page

Filters